MidState Cancer Center Re-accredited by the Commission on Cancer

Nov. 19, 2010 - PRLog -- The MidState Cancer Center is pleased to announce it has been re-accredited a three-year approval award with commendations in seven areas from the American College of Surgeons Commission on Cancer (CoC).  Accreditation from the Commission on Cancer center ensures that patients have access to high-quality comprehensive cancer services delivered by a multidisciplinary team of experts.  Accreditation also reinforces that MidState is equipped with the most innovative means to diagnosis and treat cancer, including access to sophisticated technology and ongoing clinical trials.

“We have met the vigorous standards required for a high performing program, with a focus on quality patient care in the areas of prevention, early diagnosis, state-of-the-art treatment, rehabilitation, psychosocial support and end of life care. This designation means that we have not only met all of those standards, but have exceeded them in seven areas,” said Abbi Bruce, RN, Director, Cancer Center.

These seven areas of commendation include:  producing an annual report that focuses on patient outcomes, achieving 100% compliance with case review, meeting quality criteria for the annual Commission of Cancer’s Call for Data submission, obtaining 100% compliance with College of American Pathologist protocols, offering three or more prevention or early detection programs, and implementing two quality improvement projects since the last accreditation.  Accreditation is valid through 2013.

# # #

MidState Medical Center, located in Meriden, Conn, consistently rates among the top hospitals in Connecticut and the nation. For information, visit www.midstatemedical.org.